Procurement Summary
Country : Finland
Summary : Monoclonal Antibodies for the Period 1.1.-31.12.2024 Option Year 2025
Deadline : 28 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 82295662
Document Ref. No. : 252558-2023
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The object of acquisition are monoclonal antibodies that belong to ATC group L01F and combination preparations containing only monoclonal antibodies in ATC group L01xY. Offered medicinal products must have a marketing authorization in Finland and must be available for sale and available in Finland on 1.1.2024.
Doc Title: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Contract Type: Supplies
Document Type : Prior information notice without call for competition
Reference Number : 2023/S 084-252558
Contract Type : Supplies
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Authority Type : Body governed by public law
Type of Procedure :Not applicable
Regulation : European Union, with participation by GPA countries
Bid Type : Submission for all lots
Doc Title : General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Dispatch Date : 2023-04-25
Publish Date : 2023-04-28
Submission Date : 2024-04-28
Documents
Tender Notice